Not yet recruitingEarly Phase 1NCT06559644

Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The First Affiliated Hospital of Soochow University
Principal Investigator
Xiaowen Tang
The First Affiliated Hospital of Soochow University
Intervention
Hema-NeoTIL01(biological)
Enrollment
20 enrolled
Eligibility
18-70 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06559644 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials